These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 2707520

  • 21. [Use of ursodeoxycholic acid combined with silymarin in the treatment of chronic ethyl-toxic hepatopathy].
    Bettini R, Gorini M.
    Clin Ter; 2002; 153(5):305-7. PubMed ID: 12510413
    [Abstract] [Full Text] [Related]

  • 22. [Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C].
    Pár A, Róth E, Rumi G, Kovács Z, Nemes J, Mózsik G.
    Orv Hetil; 2000 Jul 23; 141(30):1655-9. PubMed ID: 10962902
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. No effect of long-term oral testosterone treatment on liver morphology in men with alcoholic cirrhosis.
    Gluud C, Christoffersen P, Eriksen J, Wantzin P, Knudsen BB.
    Am J Gastroenterol; 1987 Jul 23; 82(7):660-4. PubMed ID: 3300274
    [Abstract] [Full Text] [Related]

  • 26. [Results of two double-blind studies on the effect of silymarine in chronic hepatitis (author's transl)].
    Kiesewetter E, Leodolter I, Thaler H.
    Leber Magen Darm; 1977 Oct 23; 7(5):318-23. PubMed ID: 926982
    [Abstract] [Full Text] [Related]

  • 27. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb 23; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 28. Milk thistle for alcoholic and/or hepatitis B or C liver diseases--a systematic cochrane hepato-biliary group review with meta-analyses of randomized clinical trials.
    Rambaldi A, Jacobs BP, Iaquinto G, Gluud C.
    Am J Gastroenterol; 2005 Nov 23; 100(11):2583-91. PubMed ID: 16279916
    [Abstract] [Full Text] [Related]

  • 29. [The effect of Cpd 861 on chronic hepatitis B related fibrosis and early cirrhosis: a randomized, double blind, placebo controlled clinical trial].
    Yin SS, Wang BE, Wang TL, Jia JD, Qian LX.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug 23; 12(8):467-70. PubMed ID: 15329205
    [Abstract] [Full Text] [Related]

  • 30. Colchicine in the treatment of cirrhosis of the liver.
    Kershenobich D, Vargas F, Garcia-Tsao G, Perez Tamayo R, Gent M, Rojkind M.
    N Engl J Med; 1988 Jun 30; 318(26):1709-13. PubMed ID: 3287167
    [Abstract] [Full Text] [Related]

  • 31. Hepatoprotective and immunomodulatory effects of antioxidant therapy.
    Láng I, Deák G, Nékám K, Müzes G, González-Cabello R, Gergely P, Fehér J.
    Acta Med Hung; 1988 Jun 30; 45(3-4):287-95. PubMed ID: 3074277
    [Abstract] [Full Text] [Related]

  • 32. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S, Gatterbauer E, Rehak P, Baumhackl U.
    J Neurol; 2003 Mar 30; 250(3):347-51. PubMed ID: 12638027
    [Abstract] [Full Text] [Related]

  • 33. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K, Kato Y, Kohno H, Takano K, Tanaka T, Teramoto A, Shimatsu A.
    Growth Horm IGF Res; 2008 Aug 30; 18(4):307-17. PubMed ID: 18282776
    [Abstract] [Full Text] [Related]

  • 34. Non-interferon-based therapy: an option for amelioration of necro-inflammation in hepatitis C patients who cannot afford interferon therapy.
    El-Zayadi AR, Attia M, Badran HM, El-Tawil A, Zalata K, Barakat E, Selim O, El-Nakeeb A, Saied A.
    Liver Int; 2005 Aug 30; 25(4):746-51. PubMed ID: 15998425
    [Abstract] [Full Text] [Related]

  • 35. Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver.
    Ferenci P, Dragosics B, Dittrich H, Frank H, Benda L, Lochs H, Meryn S, Base W, Schneider B.
    J Hepatol; 1989 Jul 30; 9(1):105-13. PubMed ID: 2671116
    [Abstract] [Full Text] [Related]

  • 36. Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis.
    Temple AR, Benson GD, Zinsenheim JR, Schweinle JE.
    Clin Ther; 2006 Feb 30; 28(2):222-35. PubMed ID: 16678643
    [Abstract] [Full Text] [Related]

  • 37. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
    Kircheis G, Nilius R, Held C, Berndt H, Buchner M, Görtelmeyer R, Hendricks R, Krüger B, Kuklinski B, Meister H, Otto HJ, Rink C, Rösch W, Stauch S.
    Hepatology; 1997 Jun 30; 25(6):1351-60. PubMed ID: 9185752
    [Abstract] [Full Text] [Related]

  • 38. Hepatoprotective and immunological effects of antioxidant drugs.
    Láng I, Nékám K, González-Cabello R, Mũzes G, Gergely P, Fehér J.
    Tokai J Exp Clin Med; 1990 May 30; 15(2-3):123-7. PubMed ID: 1983370
    [Abstract] [Full Text] [Related]

  • 39. A prospective randomized clinical trial of peripheral amino acid-glucose supplementation in acute alcoholic hepatitis.
    Achord JL.
    Am J Gastroenterol; 1987 Sep 30; 82(9):871-5. PubMed ID: 3307390
    [Abstract] [Full Text] [Related]

  • 40. Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial.
    Vinik AI, Bril V, Kempler P, Litchy WJ, Tesfaye S, Price KL, Bastyr EJ, MBBQ Study Group.
    Clin Ther; 2005 Aug 30; 27(8):1164-80. PubMed ID: 16199243
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.